MKI67 and breast cancer: Although there is no adequate evidence to explain the role of MKP-2 in BC proliferation and progression, it has been shown that low MKP-2 expression strongly correlates with a high Ki-67 score, and patients who lost MKP-2 expression had an increased Ki-67 score after neoadjuvant chemotherapy [31].